|
Section Director: Athena Milatovich Cherry, Ph.D.
Operations Director: Cynthia Samson, MA, MT(ASCP) SH, CL
General Information
The Stanford Cytogenetics Laboratory is a full-service cytogenetics laboratory. Standard chromosomal (or cytogenetic) analyses are performed on all tissue types, including:
- Amniotic fluid, chorionic villi sampling (CVS) and percutaneous umbilical blood sampling (PUBS) for prenatal diagnosis;
- Bone marrow aspirates on patients with leukemia, lymphoma and other hematological disorders;
- Peripheral blood samples in couples with multiple miscarriages;
- Peripheral blood samples of children with multiple congenital anomalies and mental retardation;
- Tumor samples of solid neoplasms and tissue (products of conception, fetal skin samples, etc.);
- Fluorescence in situ hybridization (FISH) for:
- Microdeletion syndromes
- Identification of marker chromosomes
- Leukemia/lymphoma-specific rearrangements
- HER2 amplification in breast cancer
- Screening for recurrent bladder cancer (UroVysion)
- Subtelomeric repeat studies for cryptic translocations
TO SEND A SPECIMEN FOR CONSULTATION
| TESTS: Select a test to view Test Description & Clinical Indications | TEST CODES:
Select a Test Code to view Test Specimen Collection Instructions |
| -5/5Q- SEEN IN MDS, AML AND SECONDARY MDS AND AML | CGFi5Q | | -7/7Q- | CGFi 7Q | | 13Q DELETION IN MULTIPLE MYELOMA | CGFi 13Q | | 1P DELETION/19Q DELETION IN GLIOMAS [FRESH TUMOR TISSUE OR PARAFFIN-EMBEDDED TISSUE] | FISH GLIOMA | | 4P- SYNDROME (WOLF-HIRSCHHORN SYNDROME), 4P16.3 | CGF MCDEL | | 5P- SYNDROME (CRI DU CHAT SYNDROME), 5P15.2 | CGF MCDEL | | ANGELMAN SYNDROME (AS), 15Q11.2 (D15S10 DELETION) | CGF ANGLM | | ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH) | CGH GEN | | BCR/ABL GENE FUSION IN CML AND ALL, T(9;22)(Q34;Q11.2) | CGFi BCR | | CBFB INVERSION/DELETION/TRANSLOCATION, INV(16)(P13Q22)/DEL(16Q)/T(16Q;?) IN AML-M4 | CGFi inv(16) | | CCND1/IGH GENE FUSION IN MANTLE CELL LYMPHOMA, T(11;14)(Q13;Q32) | CGFi MCL | | CENTROMERE PROBES (CROSS SEX TRANSPLANT; ANAUPLOIDY) | CGFi ENUM | | CHROMOSOME SPECIFIC SUBTELOMERIC PROBES | CGF MAR | | CLL PANEL (+12, 11Q AND 13Q DELETION, 17P DELETION) [PERIPHERAL BLOOD PREFERRED] | CGFi CLL | | CYTOGENETIC STUDY - AMNIOTIC FLUID | CGAMNIO | | CYTOGENETIC STUDY, BLOOD (CANCER DX.) | CG BLD NEO | | CYTOGENETIC STUDY, BLOOD, HIGH RESOLUTION | CG HI RES | | CYTOGENETIC STUDY, BLOOD, ROUTINE / PERCUTANEOUS UMBILICAL BLOOD SAMPLING (PUBS) | CG BLOOD | | CYTOGENETIC STUDY, BONE MARROW | CG BONE MRW | | CYTOGENETIC STUDY, CHORIONIC VILLI | CGCVS | | CYTOGENETIC STUDY, CHROMOSOME BREAKAGE FOR ATAXIA TELANGIECTASIA | CG ATAXIA | | CYTOGENETIC STUDY, CHROMOSOME BREAKAGE FOR FANCONI ANEMIA | CG FANCONI | | CYTOGENETIC STUDY, POC, TISSUE | CG TISS POC | | CYTOGENETIC STUDY, SKIN, TISSUE | CG TISS SKIN | | CYTOGENETIC STUDY, TUMOR | CG TUMOR | | DIGEORGE SEQUENCE/VELOCARDIOFACIAL SYNDROME (VCF), 22Q11.2 (TUPLE1 DELETION) AND DISTAL 22Q13.3 DELETION (ARSA) | CGF VCF | | ETO/AML1 GENE FUSION, T(8;21)(Q22;Q22), IN AML-M2 | CGFi t(8;21) | | EWS REARRANGEMENT, 22Q12 IN EWING'S SARCOMA, PNET, ETC.[FRESH TUMOR TISSUE OR PARAFFIN-EMBEDDED TISSUE] | CGFi EWS or FISH EWS | | FISH CHIC 2; DELETION (OR FIP1L1/PDGFRA FUSION) IN HES AND SMCD | CGFi CHIC2 | | FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TESTING, PRENATAL PANEL | CGF PRENAT | | HER2 AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION (FISH) IN BREAST CANCER | FISH HER2 | | HER2 AMPLIFICATION IN BREAST CANCER [*PARAFFIN-EMBEDDED TISSUE] | FISH HER2 | | IGH/BCL2 GENE FUSION IN NHL, T(14;18)(Q32;Q21) | CGFi FCL | | MILLER-DIEKER SYNDROME (MDS), 17P13.3 (LIS1 DELETION) | CGF MDK | | MLL GENE REARRANGEMENT, 11Q23, IN AML AND ALL | CGFi MLL | | MYC GENE REARRANGEMENT, 8Q24, T(8;14)(Q24;Q32), T(2;8), T(8;22) | CGFi cMYC or FISH BURKITT | | OTHER UNIQUE SEQUENCE PROBES | CGF MAR | | PML/RARA GENE FUSION IN APL, T(15;17)(Q22;Q21) | CGFi APL | | PRADER-WILLI SYNDROME (PWS), 15Q11.2 (SNRPN DELETION) | CGF PWS | | PRENATAL FISH FOR TRISOMIES 13, 18 AND 21, X AND Y CHROMOSOMES (5-10 ML DIRECT AMNIOTIC FLUID) | CGF PRENAT | | SMITH-MAGENIS SYNDROME (SMS), 17P11.2 (FL1 DELETION) | CGF SMS | | SUBTELOMERIC FISH STUDIES FOR CRYPTIC REARRANGEMENTS | CGF SUBTL | | SYT REARRANGEMENT, 18Q11.2, IN SYNOVIAL SARCOMA, T(X;18) [*FRESH TUMOR TISSUE OR PARAFFIN-EMBEDDED TISSUE] | CGFi SYT or FISH SYN SARC | | TEL/AML1 GENE FUSION IN ALL, T(12;21)(P13;Q22) | CGFi TEL | | TRISOMY 8 | CGFi ENUM | | UROVYSION FLUORESCENCE IN SITU HYBRIDIZATION (FISH) SCREENING RECURRENT BLADDER CANCER | CGFi UROV | | UROVYSION SCREEN FOR RECURRENT BLADDER CANCER (ANEUPLOIDY OF CHROMOSOMES 3, 7 AND 17; DELETION OF 9P21) [VOIDED URINE] | CGFi UROV | | WHOLE CHROMOSOME PAINTS (TO IDENTIFY UNKNOWN REARRANGEMENTS/MARKERS) | CGF WCPan | | WILLIAMS SYNDROME (WS), 7Q11.23 (WSCR DELETION) | CGF WMS | | X-LINKED ICHTHYOSIS, XP22.3 (STEROID SULFATASE DELETION) | CGF MCDEL |
Looking for a test that isn't listed? View all tests on our Test Directory Hours
Specimens are accepted 24 hours a day, seven days a week, except as noted in test specimen requirements.
Consultation Services
We provide a full range of cytogenetic diagnostic and consulting services for adult, pediatric, and prenatal samples. For consultation services please call Customer Services AT 1-877-717-3733 and request the Cytogenetics Laboratory.
Contact Information
Dana Bangs
Cytogenetic Laboratory, Supervisor
(650) 725-7476
|
